Bodø
Bodø
Bodø, Nordland, Norway10 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) | Neoplasms by Site, Skin and Connective Tissue Diseases, autosomal dominant Parkinson disease 4, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 3 | 2026-10-06 | NCT06966700 | |
| Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Not applicable | 2026-09-21 | NCT05744310 | |
| D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Phase 2 | 2026-06-04 | NCT07312110 | |
| A Multicentre Randomised Controlled Trial of the Norwegian Health in Work Service. The NSAC Efficacy Study | Fatigue, Neurologic Manifestations, Occupational Diseases, Occupational Stress, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Workplace Bullying, anxiety disorder, depressive disorder, musculoskeletal system disorder, psychiatric disorder | Active, not recruiting | Not applicable | 2026-05-08 | NCT05310695 | |
| Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes | Arterial Occlusive Diseases, Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, arteriosclerosis disorder, cardiovascular disorder, hyperlipidemia, metabolic disease, vascular disorder | Active, not recruiting | Phase 3 | 2026-04-23 | NCT06008756 | |
| A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study | Fatigue, Neurologic Manifestations, Occupational Diseases, Occupational Stress, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Workplace Bullying, anxiety disorder, depressive disorder, musculoskeletal system disorder, psychiatric disorder | Active, not recruiting | Not applicable | 2026-04-13 | NCT05006976 | |
| Clinical Research on Acute Intermittent Porphyria and the Use of Carbohydrate-Rich Diet as a Treatment | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, acute intermittent porphyria, hepatic porphyria, hereditary disease, hereditary skin disorder, liver disorder, metabolic disease, porphyria, skin disorder | Recruiting | Not applicable | 2026-03-27 | NCT06273644 | |
| Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension | Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, metabolic disease | Active, not recruiting | Phase 3 | 2025-10-07 | NCT06492291 | |
| Physical Function, Health and Employment for People With Multiple Sclerosis | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Active, not recruiting | Not applicable | 2024-11-21 | NCT06110468 | |
| Safer Personalised Cancer Treatment Digital Follow-up | Patient Reported Outcome Measure | Recruiting | Not applicable | 2024-06-26 | NCT06476158 |